p53 Immunohistochemistry of ulcerative colitis-associated with dysplasia and carcinoma

Pathology International

Volumn 49, Issue 10, 1999, Pages 858-868

  Sato, Akira ^a,b   Machinami, Rikuo ^b  

^a Takamatsu Heiwa Hospital   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Colorectal carcinoma; Colorectal carcinoma p53; Dysplasia; Immunohistochemistry; Ulcerative colitis

Indexed keywords

PROTEIN P53;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COLORECTAL CARCINOMA; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DYSPLASIA; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REMISSION; ULCERATIVE COLITIS;

ADENOMA; ADOLESCENT; ADULT; AGED; BIOPSY; CARCINOMA; CHILD; COLITIS, ULCERATIVE; COLON; COLONIC DISEASES; COLONIC NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; MIDDLE AGED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032705478     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1827.1999.00965.x     Document Type: Article

References (39)

1. Morson BC, Dawson IMP, Day DW, Jass JR, Price AB, Williams GT. Ulcerative colitis. In: Gastrointestinal Pathology, 3rd edn. Blackwell Scientific Publications, Oxford, 1990: 491-514.
2. Lewin KJ, Riddell RH, Weinstein WM. Ulcerative colitis, carcinoma in ulcerative colitis, dysplasia in inflammatory bowel disease. In: Gastrointestinal Pathology and Its Clinical Implications. Igaku-shoin, Tokyo, 1992: 839-857.
3. Vogelstein B, Fearon ER, Hamilton SR et al. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 1988; 319: 525-532.
4. Fearon ER, Vogelstein B. A genetic model for colorectal tumori-genesis (review). Cell 1990; 61: 759-767.
5. Cho KR, Vogelstein B. Genetic alterations in the adenomacarcinoma sequence. Cancer 1992; 70: 1727-1731.
6. Redston MS, Papadopoulos N, Caldas C, Kinzler KW, Kern SE. Common occurrence of APC and K-ras gene mutations in the spectrum of colitis associated neoplasias. Gastroenterology 1995; 108: 383-392.
7. Tarmin L, Yin J, Harpaz N et al. Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms. Cancer Res. 1995; 55: 2035-2038.
8. Greenwald BD, Harpaz N, Yin J et al. Loss of heterozygosity affecting the p53, Rb and MCC/APC tumor suppressor genes in dysplastic and cancerous ulcerative colitis. Cancer Res. 1992; 52: 741-745.
9. Taylor HW, Boyle M, Smith SC, Bustin S, Williams NS. Expression of p53 in colorectal cancer and dysplasia complicating ulcerative colitis. Br. J. Surg. 1993; 80: 442-444.
10. Chaubert P, Benhattar J, Saraga E, Costa J. K-ras mutations and p53 alterations in neoplastic lesions and nonneoplastic lesions associated with longstanding ulcerative colitis. Am. J. Pathol. 1994; 144: 767-775.
11. Harpaz N, Peck AL, Yin J, Fiel I, Hontanosas M, Tong TR. p53 protein expression in ulcerative colitis-associated colorectal dysplasia and carcinoma. Hum. Pathol. 1994; 25: 1069-1074.
12. Ajioka Y, Watanabe H, Matsuda K. Over-expression of p53 protein in neoplastic changes in ulcerative colitis. J Gastroenterol. 1995; 30 (Suppl. 8): 33-35.
13. Burmer GC, Rabinovitch PS, Haggitt RC et al. Neoplastic progression in ulcerative colitis: Histology, DNA content and loss of a p53 allele. Gatroenterology 1992; 103: 1602-1610.
14. Brentnall TA, Crispin DA, Rabinovitch PS et al. Mutations in the p55 gene: An early marker of neoplastic progression in ulcerative colitis. Gastroenterology 1994; 107: 369-378.
15. Yin J, Harpaz N, Tong Y et al. p53 point mutations in dysplastic and cancerous ulcerative colitis lesions. Gastroenterology 1993; 104: 1633-1639.
16. Ilyas M, Talbot IC. p53 expression in ulcerative colitis: A longitudinal study. Gut 1995; 37: 802-804.
17. Warren S, Sommers SC. Pathogenesis of ulcerative colitis. Am. J. Pathol. 1947; 25: 657-679.
18. Riddell RH, Goldman H, Ransohoff DF et al. Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications. Hum. Pathol. 1983; 4: 931-968.
19. Lennard-Jones JE, Morson BC, Ritchie JK, Williams CB. Cancer surveillance in ulcerative colitis. Experience over 15 years. Lancet 1983; 11: 149-152.
20. Leidenius M, Kellokumpu I, Husa A, Riihela M, Sipponen P. Dysplasia and carcinoma in long-standing ulcerative colitis: An endoscopic and histological surveillance programme. Gut 1991; 32: 1521-1525.
21. Choi PM, Nugent FW, Schoetz DJ Jr, Silverman ML, Haggitt RC. Colonoscopic surveillance reduces mortality from colorectal cancer. Gastroenterology 1993; 105: 418-424.
22. Konishi F, Wakasa H, Kino I, Watanabe H, Nagura H, Muto T. Histological classification of the neoplastic changes arising in ulcerative colitis: A new proposal in Japan. Gastroenterology 1995; 30 (Suppl. VIII): 20-24.
23. Lewin KJ. Nomenclature problems of gastrointestinal epithelial neoplasia (editorial). Am. J. Surg. Pathol. 1998; 22: 1043-1047.
24. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 1991; 51: 6304-6311.
25. Kawasaki Y, Monden T, Morimoto H et al. Immunohistochemical study of p53 expression in microwave-fixed, paraffin-embedded sections of colorectal carcinoma and adenoma. Am. J. Clin. Pathol. 1992; 97: 244-249.
26. Bertorelle R, Esposito G, Mistro AD et al. Association of p53 gene and protein alterations with metastasis in colorectal cancer. Am. J. Surg. Pathol. 1995; 19: 463-471.
27. Matsuda K, Watanabe H, Jass JR et al. Frequency of p53-positive cells in differing histological phases of ulcerative colitis. Acta Med. Biol. 1995; 43: 197-203.
28. Krishna M, Woda B, Savas L, Baker S, Banner B. Expression of p53 antigen in inflamed and regenerated mucosa in ulcerative colitis and Crohn's disease. Mod. Pathol. 1995; 8: 654-657.
29. Maruyama K, Saigusa N, Baba S, Kino I. Immunohistochemical distribution of p53 and Ki-67 in 2 cases of colorectal carcinoma occurring in ulcerative colitis (in Japanese). Jpn. J. Cancer Chemother. 1995; 22 (Suppl. II): 145-148.
30. Wynford-Thomas D. p53 in tumour pathology: Can we trust immunocytochemistry? (Editorial). J. Pathol. 1992; 166: 329-330.
31. Hall PA, Lane DP. p53 in tumour pathology: Can we trust immunohistochemistry? -Revisited! (Editorial). J. Pathol. 1994; 172: 1-4.
32. Locker J. Tumor suppressor genes and the practice of surgical pathology. Hum. Pathol. 1995; 26: 359-361.
33. Matsuda K, Watanabe H, Ajioka Y. Ulcerative colitis and colon cancer (in Japanese). Mod. Med. 1995; 32: 1158-1168.
34. Tsuda T. Clinicopathological, histochemical and immunohistochemical study of dysplasia and carcinoma complicating ulcerative colitis (in Japanese). J. Jpn. Soc. Colo-Proctol. 1993; 46: 853-868.
35. Suzuki K, Muto T, Masaki T, Morioka Y. Microspectrophotometric DNA analysis in ulcerative colitis with special reference to its application in diagnosis of cancer and dysplasia. Gut 1990; 31: 1266-1270.
36. Matsuda K, Watanabe H, Ajioka Y et al. Ulcerative colitis with overexpression of p53 preceding overt histological abnormalities of the epithelium. J. Gastroenterol. 1996; 31: 860-867.
37. Fogt F, Vortmeyer AO, Goldman H, Giordano TJ, Merino MJ, Zhuang Z. Comparison of genetic alterations in colonic adenoma and ulcerative colitis-associated dysplasia and carcinoma. Hum. Pathol. 1998; 29: 131-136.
38. Holzmann K, Klump B, Borchard F et al. Comparative analysis of histology, DNA content, p53 and Ki-ras mutations in colectomy specimens with long-standing ulcerative colitis. Int. J. Cancer 1998; 76: 1-6.
39. Butt JH, Konishi F, Morson BC, Lennard-Jones JE, Ritchie JK. Macroscopic lesions in dysplasia and carcinoma complicating ulcerative colitis. Dig. Dis. Sci. 1983; 28: 18-26.